364 related articles for article (PubMed ID: 23033341)
1. Genome and transcriptome sequencing of lung cancers reveal diverse mutational and splicing events.
Liu J; Lee W; Jiang Z; Chen Z; Jhunjhunwala S; Haverty PM; Gnad F; Guan Y; Gilbert HN; Stinson J; Klijn C; Guillory J; Bhatt D; Vartanian S; Walter K; Chan J; Holcomb T; Dijkgraaf P; Johnson S; Koeman J; Minna JD; Gazdar AF; Stern HM; Hoeflich KP; Wu TD; Settleman J; de Sauvage FJ; Gentleman RC; Neve RM; Stokoe D; Modrusan Z; Seshagiri S; Shames DS; Zhang Z
Genome Res; 2012 Dec; 22(12):2315-27. PubMed ID: 23033341
[TBL] [Abstract][Full Text] [Related]
2. Genetic and epigenetic screening for gene alterations of the chromatin-remodeling factor, SMARCA4/BRG1, in lung tumors.
Medina PP; Carretero J; Fraga MF; Esteller M; Sidransky D; Sanchez-Cespedes M
Genes Chromosomes Cancer; 2004 Oct; 41(2):170-7. PubMed ID: 15287030
[TBL] [Abstract][Full Text] [Related]
3. Dissecting the genomic complexity underlying medulloblastoma.
Jones DT; Jäger N; Kool M; Zichner T; Hutter B; Sultan M; Cho YJ; Pugh TJ; Hovestadt V; Stütz AM; Rausch T; Warnatz HJ; Ryzhova M; Bender S; Sturm D; Pleier S; Cin H; Pfaff E; Sieber L; Wittmann A; Remke M; Witt H; Hutter S; Tzaridis T; Weischenfeldt J; Raeder B; Avci M; Amstislavskiy V; Zapatka M; Weber UD; Wang Q; Lasitschka B; Bartholomae CC; Schmidt M; von Kalle C; Ast V; Lawerenz C; Eils J; Kabbe R; Benes V; van Sluis P; Koster J; Volckmann R; Shih D; Betts MJ; Russell RB; Coco S; Tonini GP; Schüller U; Hans V; Graf N; Kim YJ; Monoranu C; Roggendorf W; Unterberg A; Herold-Mende C; Milde T; Kulozik AE; von Deimling A; Witt O; Maass E; Rössler J; Ebinger M; Schuhmann MU; Frühwald MC; Hasselblatt M; Jabado N; Rutkowski S; von Bueren AO; Williamson D; Clifford SC; McCabe MG; Collins VP; Wolf S; Wiemann S; Lehrach H; Brors B; Scheurlen W; Felsberg J; Reifenberger G; Northcott PA; Taylor MD; Meyerson M; Pomeroy SL; Yaspo ML; Korbel JO; Korshunov A; Eils R; Pfister SM; Lichter P
Nature; 2012 Aug; 488(7409):100-5. PubMed ID: 22832583
[TBL] [Abstract][Full Text] [Related]
4. Antagonistic SR proteins regulate alternative splicing of tumor-related Rac1b downstream of the PI3-kinase and Wnt pathways.
Gonçalves V; Matos P; Jordan P
Hum Mol Genet; 2009 Oct; 18(19):3696-707. PubMed ID: 19602482
[TBL] [Abstract][Full Text] [Related]
5. Systematic identification of cancer-related long noncoding RNAs and aberrant alternative splicing of quintuple-negative lung adenocarcinoma through RNA-Seq.
Zhang L; Li S; Choi YL; Lee J; Gong Z; Liu X; Pei Y; Jiang A; Ye M; Mao M; Zhang X; Kim J; Chen R
Lung Cancer; 2017 Jul; 109():21-27. PubMed ID: 28577945
[TBL] [Abstract][Full Text] [Related]
6. The transcriptional landscape and mutational profile of lung adenocarcinoma.
Seo JS; Ju YS; Lee WC; Shin JY; Lee JK; Bleazard T; Lee J; Jung YJ; Kim JO; Shin JY; Yu SB; Kim J; Lee ER; Kang CH; Park IK; Rhee H; Lee SH; Kim JI; Kang JH; Kim YT
Genome Res; 2012 Nov; 22(11):2109-19. PubMed ID: 22975805
[TBL] [Abstract][Full Text] [Related]
7. SMARCA4-inactivating mutations increase sensitivity to Aurora kinase A inhibitor VX-680 in non-small cell lung cancers.
Tagal V; Wei S; Zhang W; Brekken RA; Posner BA; Peyton M; Girard L; Hwang T; Wheeler DA; Minna JD; White MA; Gazdar AF; Roth MG
Nat Commun; 2017 Jan; 8():14098. PubMed ID: 28102363
[TBL] [Abstract][Full Text] [Related]
8. Mechanism of BRG1 silencing in primary cancers.
Marquez-Vilendrer SB; Thompson K; Lu L; Reisman D
Oncotarget; 2016 Aug; 7(35):56153-56169. PubMed ID: 27486753
[TBL] [Abstract][Full Text] [Related]
9. Expression inactivation of SMARCA4 by microRNAs in lung tumors.
Coira IF; Rufino-Palomares EE; Romero OA; Peinado P; Metheetrairut C; Boyero-Corral L; Carretero J; Farez-Vidal E; Cuadros M; Reyes-Zurita FJ; Lupiáñez JA; Sánchez-Cespedes M; Slack FJ; Medina PP
Hum Mol Genet; 2015 Mar; 24(5):1400-9. PubMed ID: 25355421
[TBL] [Abstract][Full Text] [Related]
10. A small-cell lung cancer genome with complex signatures of tobacco exposure.
Pleasance ED; Stephens PJ; O'Meara S; McBride DJ; Meynert A; Jones D; Lin ML; Beare D; Lau KW; Greenman C; Varela I; Nik-Zainal S; Davies HR; Ordoñez GR; Mudie LJ; Latimer C; Edkins S; Stebbings L; Chen L; Jia M; Leroy C; Marshall J; Menzies A; Butler A; Teague JW; Mangion J; Sun YA; McLaughlin SF; Peckham HE; Tsung EF; Costa GL; Lee CC; Minna JD; Gazdar A; Birney E; Rhodes MD; McKernan KJ; Stratton MR; Futreal PA; Campbell PJ
Nature; 2010 Jan; 463(7278):184-90. PubMed ID: 20016488
[TBL] [Abstract][Full Text] [Related]
11. Dual loss of the SWI/SNF complex ATPases SMARCA4/BRG1 and SMARCA2/BRM is highly sensitive and specific for small cell carcinoma of the ovary, hypercalcaemic type.
Karnezis AN; Wang Y; Ramos P; Hendricks WP; Oliva E; D'Angelo E; Prat J; Nucci MR; Nielsen TO; Chow C; Leung S; Kommoss F; Kommoss S; Silva A; Ronnett BM; Rabban JT; Bowtell DD; Weissman BE; Trent JM; Gilks CB; Huntsman DG
J Pathol; 2016 Feb; 238(3):389-400. PubMed ID: 26356327
[TBL] [Abstract][Full Text] [Related]
12. A comparative and integrative approach identifies ATPase family, AAA domain containing 2 as a likely driver of cell proliferation in lung adenocarcinoma.
Fouret R; Laffaire J; Hofman P; Beau-Faller M; Mazieres J; Validire P; Girard P; Camilleri-Bröet S; Vaylet F; Leroy-Ladurie F; Soria JC; Fouret P
Clin Cancer Res; 2012 Oct; 18(20):5606-16. PubMed ID: 22914773
[TBL] [Abstract][Full Text] [Related]
13. A pan-cancer analysis of transcriptome changes associated with somatic mutations in U2AF1 reveals commonly altered splicing events.
Brooks AN; Choi PS; de Waal L; Sharifnia T; Imielinski M; Saksena G; Pedamallu CS; Sivachenko A; Rosenberg M; Chmielecki J; Lawrence MS; DeLuca DS; Getz G; Meyerson M
PLoS One; 2014; 9(1):e87361. PubMed ID: 24498085
[TBL] [Abstract][Full Text] [Related]
14. Medulloblastoma exome sequencing uncovers subtype-specific somatic mutations.
Pugh TJ; Weeraratne SD; Archer TC; Pomeranz Krummel DA; Auclair D; Bochicchio J; Carneiro MO; Carter SL; Cibulskis K; Erlich RL; Greulich H; Lawrence MS; Lennon NJ; McKenna A; Meldrim J; Ramos AH; Ross MG; Russ C; Shefler E; Sivachenko A; Sogoloff B; Stojanov P; Tamayo P; Mesirov JP; Amani V; Teider N; Sengupta S; Francois JP; Northcott PA; Taylor MD; Yu F; Crabtree GR; Kautzman AG; Gabriel SB; Getz G; Jäger N; Jones DT; Lichter P; Pfister SM; Roberts TM; Meyerson M; Pomeroy SL; Cho YJ
Nature; 2012 Aug; 488(7409):106-10. PubMed ID: 22820256
[TBL] [Abstract][Full Text] [Related]
15. The molecular landscape of histone lysine methyltransferases and demethylases in non-small cell lung cancer.
Li J; Tao X; Shen J; Liu L; Zhao Q; Ma Y; Tao Z; Zhang Y; Ding B; Xiao Z
Int J Med Sci; 2019; 16(7):922-930. PubMed ID: 31341405
[No Abstract] [Full Text] [Related]
16. Aberrant transcriptional regulations in cancers: genome, transcriptome and epigenome analysis of lung adenocarcinoma cell lines.
Suzuki A; Makinoshima H; Wakaguri H; Esumi H; Sugano S; Kohno T; Tsuchihara K; Suzuki Y
Nucleic Acids Res; 2014 Dec; 42(22):13557-72. PubMed ID: 25378332
[TBL] [Abstract][Full Text] [Related]
17. Aberrant patterns of H3K4 and H3K27 histone lysine methylation occur across subgroups in medulloblastoma.
Dubuc AM; Remke M; Korshunov A; Northcott PA; Zhan SH; Mendez-Lago M; Kool M; Jones DT; Unterberger A; Morrissy AS; Shih D; Peacock J; Ramaswamy V; Rolider A; Wang X; Witt H; Hielscher T; Hawkins C; Vibhakar R; Croul S; Rutka JT; Weiss WA; Jones SJ; Eberhart CG; Marra MA; Pfister SM; Taylor MD
Acta Neuropathol; 2013 Mar; 125(3):373-84. PubMed ID: 23184418
[TBL] [Abstract][Full Text] [Related]
18. Massive parallel DNA pyrosequencing analysis of the tumor suppressor BRG1/SMARCA4 in lung primary tumors.
Rodriguez-Nieto S; Cañada A; Pros E; Pinto AI; Torres-Lanzas J; Lopez-Rios F; Sanchez-Verde L; Pisano DG; Sanchez-Cespedes M
Hum Mutat; 2011 Feb; 32(2):E1999-2017. PubMed ID: 21280140
[TBL] [Abstract][Full Text] [Related]
19. Targeted DNA and RNA Sequencing of Paired Urothelial and Squamous Bladder Cancers Reveals Discordant Genomic and Transcriptomic Events and Unique Therapeutic Implications.
Hovelson DH; Udager AM; McDaniel AS; Grivas P; Palmbos P; Tamura S; Lazo de la Vega L; Palapattu G; Veeneman B; El-Sawy L; Sadis SE; Morgan TM; Montgomery JS; Weizer AZ; Day KC; Neamati N; Liebert M; Keller ET; Day ML; Mehra R; Tomlins SA
Eur Urol; 2018 Dec; 74(6):741-753. PubMed ID: 30033047
[TBL] [Abstract][Full Text] [Related]
20. Histone 3 lysine-27 demethylase KDM6A coordinates with KMT2B to play an oncogenic role in NSCLC by regulating H3K4me3.
Leng X; Wang J; An N; Wang X; Sun Y; Chen Z
Oncogene; 2020 Oct; 39(41):6468-6479. PubMed ID: 32879445
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
